Study #2018-0559
A Combination Therapy to Treat Cancer-Related Fatigue - NCI R01
MD Anderson Study Status
Enrolling
Treatment Agent
Methylphenidate
Description
This phase II/III trial studies how well methylphenidate and exercise work in reducing cancer-related fatigue in patients with prostate cancer. Methylphenidate is a type of central nervous system stimulant that can improve cognitive ability, mainly in memory and cognitive function. Exercise can improve mood and the physical aspects of cancer-related fatigue. Giving methylphenidate in combination with exercise may work better in reducing cancer-related fatigue in patients with prostate cancer.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Prostate Carcinoma
Study phase:
Phase II/III
Physician name:
Sriram Yennu
Department:
Palliative Care & Rehabilitation Medicine
For general questions about clinical trials:
1-844-317-6206
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.